WA-AMAZON.COM
1.8.2019 12:02:06 CEST | Business Wire | Press release
Amazon (NASDAQ: AMZN) today announced the company’s 65th and 66th renewable energy projects. Amazon’s newest renewable energy project in the EU will be located in Cork, Ireland, and will be the second Amazon Wind Farm in the Republic of Ireland. Once complete, the new Amazon Wind Farm will provide 23.2 megawatts (MW) of renewable capacity, with expected generation of 68,000 megawatt hours (MWh) of clean energy annually. Amazon’s newest renewable energy project in the U.S. will be located in Pittsylvania County, Virginia, and will be the seventh Amazon Solar Farm in the Commonwealth of Virginia. Once complete, the new Amazon Solar Farm will provide 45 megawatts (MW) of renewable capacity and is expected to generate 100,000 megawatt hours (MWh) of clean energy annually. Both projects are expected to begin producing clean energy in 2020 and will supply clean energy to the company’s Amazon Web Services datacenters, which power Amazon and millions of AWS customers globally.
Additionally, Amazon’s investments in renewable energy were recently recognized in the Solar Energy Industries Association’s (SEIA) 2018 Solar Means Business Report , which ranked Amazon #1 in the U.S. for amount of corporate on-site solar installed in 2018, and #2 for total amount of solar installed to date. Amazon’s solar projects in the U.S. have offset the CO2 equivalent of more than 200 million miles of truck deliveries. Globally, Amazon has 66 renewable energy projects – including 51 solar rooftops – that are expected to generate 1,342 MW of renewable capacity and deliver more than 3.9 million MWh of clean energy annually.
“Playing a significant role in helping to reduce the sources of human-induced climate change is an important commitment for Amazon,” said Kara Hurst, Director of Sustainability, Amazon. “Major investments in renewable energy are a critical step to address our carbon footprint globally. We will continue to invest in these projects, and look forward to additional investments this year and beyond.”
“Under the Climate Action Plan, we are committing that 70 percent of Ireland’s electricity will come from renewable sources by 2030. Industry leadership is key to helping us reach this target,” said Richard Bruton, Ireland’s Minister for Communications, Climate Action and Environment. “This project is another example of AWS’s commitment to renewable projects in Ireland, adding clean energy to the grid, and supporting Ireland’s climate commitments. Construction will begin on this project this year and will start contributing to Ireland’s renewable energy capacity by 2020. We look forward to continuing to work with AWS as we strive to make Ireland a leader in the renewable energy space.”
“I applaud Amazon for their continued investment in clean and renewable energy projects in the Commonwealth of Virginia,” said Virginia Senator Mark R. Warner. “This solar energy project in Pittsylvania County will lead to a cleaner environment and more jobs in the community.”
“It’s wonderful to see the announcement of these new projects, which will help bring more renewable energy to the Commonwealth of Virginia where Amazon has already helped bring significant solar energy projects online,” said Virginia Governor Ralph Northam. “Amazon’s new solar farm in Virginia will create jobs and economic development in rural Virginia, and will continue to build upon our role as a leading state for renewable energy in the U.S.”
Beyond investments in wind and solar, Amazon has a long history of commitment to sustainability through innovative programs such as Shipment Zero , Frustration-Free Packaging, Ships in Own Container, investments in the circular economy with the Closed Loop Fund, and numerous other initiatives happening every day by teams across Amazon. Amazon has also implemented the District Energy Project that uses recycled energy to heat and cool more than 3 million square feet of office space. For more information on Amazon’s sustainability initiatives, visit www.amazon.com/sustainability .
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews .
About Amazon Web Services
For 13 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 165 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 66 Availability Zones (AZs) within 21 geographic regions, spanning the U.S., Australia, Brazil, Canada, China, France, Germany, Hong Kong Special Administrative Region, India, Ireland, Japan, Korea, Singapore, Sweden, and the UK. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190801005260/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom